A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm

Artificial intelligence (AI) is transforming pharmaceutical science by shifting drug delivery research from empirical experimentation toward predictive, data-driven innovation. This review critically examines the integration of AI across formulation design, smart drug delivery systems (DDSs), and sustainable pharmaceutics, emphasizing its role in accelerating development, enhancing personalization, and promoting environmental responsibility. AI techniques—including machine learning, deep learning, Bayesian optimization, reinforcement learning, and digital twins—enable precise prediction of critical quality attributes, generative discovery of excipients, and closed-loop optimization with minimal experimental input. These tools have demonstrated particular value in polymeric and nano-based systems through their ability to model complex behaviors and to design stimuli-responsive DDS capable of real-time therapeutic adaptation. Furthermore, AI facilitates the transition toward green pharmaceutics by supporting biodegradable material selection, energy-efficient process design, and life-cycle optimization, thereby aligning drug delivery strategies with global sustainability goals. However, challenges persist, including limited data availability, lack of model interpretability, regulatory uncertainty, and the high computational cost of AI systems. Addressing these limitations requires the implementation of FAIR data principles, physics-informed modeling, and ethically grounded regulatory frameworks. Overall, AI serves not as a replacement for human expertise but as a transformative enabler, redefining DDS as intelligent, adaptive, and sustainable platforms for future pharmaceutical development. Compared with previous reviews that have considered AI-based formulation design, smart DDS, and green pharmaceutics separately, this article integrates these strands and proposes a dual-framework roadmap that situates current AI-enabled DDS within a structured life-cycle perspective and highlights key translational gaps.

Authors

Institutions

Publication Details

Journal
Sci
Published
2025-12-03
DOI
https://doi.org/10.3390/sci7040179
Citations
2
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
1.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm

Jirapornchai Suksaeree
2 citations
Sci
Drug Solubulity and Delivery Systems
1.58
article

A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm

Jirapornchai Suksaeree
article en
2 citations

Abstract

Artificial intelligence (AI) is transforming pharmaceutical science by shifting drug delivery research from empirical experimentation toward predictive, data-driven innovation. This review critically examines the integration of AI across formulation design, smart drug delivery systems (DDSs), and sustainable pharmaceutics, emphasizing its role in accelerating development, enhancing personalization, and promoting environmental responsibility. AI techniques—including machine learning, deep learning, Bayesian optimization, reinforcement learning, and digital twins—enable precise prediction of critical quality attributes, generative discovery of excipients, and closed-loop optimization with minimal experimental input. These tools have demonstrated particular value in polymeric and nano-based systems through their ability to model complex behaviors and to design stimuli-responsive DDS capable of real-time therapeutic adaptation. Furthermore, AI facilitates the transition toward green pharmaceutics by supporting biodegradable material selection, energy-efficient process design, and life-cycle optimization, thereby aligning drug delivery strategies with global sustainability goals. However, challenges persist, including limited data availability, lack of model interpretability, regulatory uncertainty, and the high computational cost of AI systems. Addressing these limitations requires the implementation of FAIR data principles, physics-informed modeling, and ethically grounded regulatory frameworks. Overall, AI serves not as a replacement for human expertise but as a transformative enabler, redefining DDS as intelligent, adaptive, and sustainable platforms for future pharmaceutical development. Compared with previous reviews that have considered AI-based formulation design, smart DDS, and green pharmaceutics separately, this article integrates these strands and proposes a dual-framework roadmap that situates current AI-enabled DDS within a structured life-cycle perspective and highlights key translational gaps.

SciVol. 7(4)
Rangsit University (TH)
Openalex Percentile: Top 14%
Drug Solubulity and Delivery Systems
1.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm — Jirapornchai Suksaeree · Sci (2025) | TGRS Research Map | TGRS